BOSTON--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that on February 2, 2015, the Company granted stock options to seven new employees to purchase an aggregate of 210,000 shares of common stock. The stock options were granted as inducements material to the new employees entering into employment with Verastem pursuant to NASDAQ Listing Rule 5635(c)(4).
Help employers find you! Check out all the jobs and post your resume.
